1-10 items (total 20)
Published on July 27, 2026
World’s First Clinical Study of iPSC-Derived Neural Progenitor Cell Therapy for Subacute Spinal Cord Injury Supports Long-Term Safety Through Up to Four Years of Follow-up
Published on June 15, 2026
A brand-new pathway discovered in small intestinal cancer
Keio University researchers uncover a tumor-driving gene that had never been linked to cancer
Published on June 04, 2026
Mechanism of a "vicious cycle" of autoimmunity uncovered in Sjögren's disease
Discovery may enable development of therapies that selectively target disease-causing autoimmune responses
Published on March 23, 2026
Identification of Serum IL‑22 and IL‑18 as Cytokines Reflecting Disease Activity in Atopic Dermatitis During Dupilumab Therapy
― Potential for New Monitoring Indicators Accounting for Diverse Inflammatory Patterns ―
Published on November 10, 2025
A New Indicator for Predicting Recovery After Spinal Cord Injury
―miR-9-3p in cerebrospinal fluid extracellular vesicles shows neuroprotective effects, highlighting its potential as a novel biomarker
Published on October 09, 2025
Japan’s First Nationwide Survey Highlights Gaps in Patient Engagement for Allergy Research
Findings reveal strong patient advocacy but limited researcher involvement, underscoring policy priorities for patient-centered care
Published on September 24, 2025
Sjögren's Disease Pathophysiology by Autoantibody Profile:
Paving the Way for Personalized and Precision Medicine
Published on September 19, 2025
Announcement of The Keio Medical Science Prize 2025
Published on April 02, 2025
Completion of Follow-Up Observations in Clinical Study on Regenerative Medicine Using iPS Cell-Derived Neural Stem/Progenitor Cells to Treat Subacute Spinal Cord Injuries
Published on October 29, 2024